Cargando…
Doxorubicin–NO Releaser Molecular Hybrid Activatable by Green Light to Overcome Resistance in Breast Cancer Cells
[Image: see text] The biological activity of a molecular hybrid (DXNO-GR) joining doxorubicin (DOX) and an N-nitroso moiety releasing nitric oxide (NO) under irradiation with the biocompatible green light has been investigated against DOX-sensitive (MCF7) and -resistant (MDA-MB-231) breast cancer ce...
Autores principales: | Parisi, Cristina, Moret, Francesca, Fraix, Aurore, Menilli, Luca, Failla, Mariacristina, Sodano, Federica, Conte, Claudia, Quaglia, Fabiana, Reddi, Elena, Sortino, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908524/ https://www.ncbi.nlm.nih.gov/pubmed/35284722 http://dx.doi.org/10.1021/acsomega.1c03988 |
Ejemplares similares
-
A generator of peroxynitrite activatable with red light
por: Parisi, Cristina, et al.
Publicado: (2021) -
A Supramolecular Nanoassembly of Lenvatinib and a Green Light-Activatable NO Releaser for Combined Chemo-Phototherapy
por: Laneri, Francesca, et al.
Publicado: (2022) -
Pluronic(®) P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells
por: Pellosi, Diogo Silva, et al.
Publicado: (2016) -
Enhancing the Anticancer Activity of Sorafenib through Its Combination with a Nitric Oxide Photodelivering β-Cyclodextrin Polymer
por: Laneri, Francesca, et al.
Publicado: (2022) -
Combination of PDT and NOPDT with a Tailored BODIPY Derivative
por: Lazzarato, Loretta, et al.
Publicado: (2019)